DEXCOM, INC. Acquisitions, Net of Cash Acquired
DEXCOM, INC. (DXCM) reported Acquisitions, Net of Cash Acquired of $41.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-07-30
- DEXCOM, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $0.00.
- DEXCOM, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- DEXCOM, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2023-06-30 was $0.00.
- DEXCOM, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- DEXCOM, INC. payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00.
- DEXCOM, INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- DEXCOM, INC. payments to acquire businesses, net of cash acquired for fiscal 2022 was $3.90M, a 87.09% decline from fiscal 2021.
- DEXCOM, INC. payments to acquire businesses, net of cash acquired for fiscal 2021 was $30.20M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2026-06-30 | $41.20M 10-Q · filed 2026-07-30 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-07-30 | |||
| 2024-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $0.00 derived: sum of 3 quarters · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $0.00 derived: sum of 2 quarters · filed 2023-10-26 | $0.00 10-Q · filed 2023-10-26 | $0.00 derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $0.00 10-Q · filed 2023-07-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-18 | $700.00K derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $0.00 10-Q · filed 2023-04-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $700.00K derived: sum of 3 quarters · filed 2025-02-18 | $700.00K derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $700.00K derived: sum of 2 quarters · filed 2025-02-18 | $700.00K derived: sum of 3 quarters · filed 2025-02-18 | $3.90M 10-K · filed 2025-02-18 |
| 2022-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $700.00K derived: sum of 2 quarters · filed 2023-10-26 | $3.90M 10-Q · filed 2023-10-26 | $2.50M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $3.20M 10-Q · filed 2023-07-27 | $1.80M derived: sum of 3 quarters · filed 2024-02-08 | $33.40M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-03-31 | $3.20M 10-Q · filed 2023-04-27 | $1.80M derived: sum of 2 quarters · filed 2024-02-08 | $33.40M derived: sum of 3 quarters · filed 2024-02-08 | $33.40M derived: sum of 4 quarters · filed 2024-02-08 |
| 2021-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $30.20M derived: sum of 2 quarters · filed 2024-02-08 | $30.20M derived: sum of 3 quarters · filed 2024-02-08 | $30.20M 10-K · filed 2024-02-08 |
| 2021-09-30 | $31.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $31.60M derived: sum of 2 quarters · filed 2022-10-27 | $31.60M 10-Q · filed 2022-10-27 | $31.60M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $0.00 10-Q · filed 2022-07-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-04-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-09 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $0.00 10-K · filed 2023-02-09 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-10-28 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $0.00 10-K · filed 2022-02-14 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $11.30M 10-K · filed 2021-02-11 | ||
| 2018-09-30 | $11.30M 10-Q · filed 2019-11-06 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $0.00 10-K · filed 2020-02-13 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | -$300.00K 10-K · filed 2019-02-21 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $0.00 derived: sum of 2 quarters · filed 2016-02-23 | $500.00K 10-K · filed 2016-02-23 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $500.00K 10-Q · filed 2015-11-04 | ||
| 2015-06-30 | $500.00K 10-Q · filed 2015-08-05 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $0.00 derived: sum of 2 quarters · filed 2016-02-23 | $0.00 10-K · filed 2016-02-23 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 10-Q · filed 2015-11-04 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-05 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |